These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 39101178)

  • 21. A case of new-onset Fulminant type 1 diabetes after secondary SARS-CoV-2 infection.
    Wang J; Huang Y; Tao F
    Heliyon; 2024 May; 10(9):e30750. PubMed ID: 38756607
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A rare case of fulminant type 1 diabetes mellitus accompanied by both acute pancreatitis and myocarditis - case report.
    Egashira F; Kawashima M; Morikawa A; Kosuda M; Ishihara H; Watanabe K
    BMC Endocr Disord; 2020 Aug; 20(1):127. PubMed ID: 32811476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Case of Acute-Onset Type 1 Diabetes Mellitus with Diabetic Ketoacidosis Triggered by COVID-19.
    Zenri M; Higa M; Ikehara K; Ichijo T; Hirose T
    Am J Case Rep; 2023 Sep; 24():e940986. PubMed ID: 37717141
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Possible involvement of autoimmunity in fulminant type 1 diabetes.
    Oikawa Y; Shimada A
    Diabetol Int; 2020 Oct; 11(4):329-335. PubMed ID: 33088639
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Durvalumab-induced diabetic ketoacidosis followed by hypothyroidism.
    Patel S; Chin V; Greenfield JR
    Endocrinol Diabetes Metab Case Rep; 2019 Dec; 2019():. PubMed ID: 31829972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Euglycemic Diabetic Ketoacidosis With COVID-19 Infection in Patients With Type 2 Diabetes Taking SGLT2 Inhibitors.
    Vitale RJ; Valtis YK; McDonnell ME; Palermo NE; Fisher NDL
    AACE Clin Case Rep; 2021; 7(1):10-13. PubMed ID: 33521255
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diabetes Mellitus Type 1 Presenting in the Setting of Diabetic Ketoacidosis and Acute SARS-CoV-2 Infection in Pregnancy.
    Stamatiades GA; Galbiati F; Fitzgerald AC; McDonnell ME; Lassey SC; Palermo NE
    AACE Clin Case Rep; 2023 Apr; 9(4):108-11. PubMed ID: 37363439
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fulminant type 1 diabetes: 20 years of discovery and development.
    Hanafusa T
    Diabetol Int; 2020 Oct; 11(4):310-314. PubMed ID: 33088636
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of Graves' Disease After SARS-CoV-2 mRNA Vaccination: A Case Report and Literature Review.
    Lui DTW; Lee KK; Lee CH; Lee ACH; Hung IFN; Tan KCB
    Front Public Health; 2021; 9():778964. PubMed ID: 34888290
    [No Abstract]   [Full Text] [Related]  

  • 30. Diabetic Ketoacidosis Complicating Gestational Diabetes Mellitus.
    Villavicencio CA; Franco-Akel A; Belokovskaya R
    AACE Clin Case Rep; 2022; 8(5):221-223. PubMed ID: 36189139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HLA typing of patients who developed subacute thyroiditis and Graves' disease after SARS-CoV-2 vaccination: a case report.
    Yasuda S; Suzuki S; Yanagisawa S; Morita H; Haisa A; Satomura A; Nakajima R; Oikawa Y; Inoue I; Shimada A
    BMC Endocr Disord; 2023 Mar; 23(1):54. PubMed ID: 36879263
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Relationship Between COVID-19 and the Development of Diabetic Ketoacidosis and New-Onset Type 1 Diabetes Mellitus.
    Kellogg C; Haenel LC
    Cureus; 2024 May; 16(5):e60711. PubMed ID: 38903308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diabetic ketoacidosis precipitated by atypical coronavirus disease in a newly diagnosed diabetic girl.
    Albuali WH; AlGhamdi NA
    J Taibah Univ Med Sci; 2021 Aug; 16(4):628-631. PubMed ID: 34177416
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Graves' Thyrotoxicosis Following SARS-CoV-2 Infection.
    Harris A; Al Mushref M
    AACE Clin Case Rep; 2021; 7(1):14-16. PubMed ID: 33521256
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autoantibody-negative insulin-dependent diabetes mellitus after SARS-CoV-2 infection: a case report.
    Hollstein T; Schulte DM; Schulz J; Glück A; Ziegler AG; Bonifacio E; Wendorff M; Franke A; Schreiber S; Bornstein SR; Laudes M
    Nat Metab; 2020 Oct; 2(10):1021-1024. PubMed ID: 32879473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sodium-glucose co-transporter-2 inhibitor-associated euglycemic diabetic ketoacidosis that prompted the diagnosis of fulminant type-1 diabetes: A case report.
    Yasuma T; Okano Y; Tanaka S; Nishihama K; Eguchi K; Inoue C; Maki K; Uchida A; Uemura M; Suzuki T; D'Alessandro-Gabazza CN; Gabazza EC; Yano Y
    World J Clin Cases; 2021 May; 9(13):3163-3169. PubMed ID: 33969104
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nivolumab-induced autoimmune diabetes mellitus presenting as diabetic ketoacidosis in a patient with metastatic lung cancer.
    Godwin JL; Jaggi S; Sirisena I; Sharda P; Rao AD; Mehra R; Veloski C
    J Immunother Cancer; 2017; 5():40. PubMed ID: 28515940
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid improvement of severe fatty liver in a case of fulminant type 1 diabetes following insulin treatment.
    Noda S; Harai N; Komai S; Inukai T; Watanabe T; Hosokawa T; Antoku A; Muroi Y; Hayashida R; Okuma H; Suzuki Y; Tsuchiya K
    Diabetol Int; 2024 Apr; 15(2):297-301. PubMed ID: 38524939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Co-existing of Neuromyelitis Optica and Fulminant Type 1 Diabetes.
    Saheki T; Imachi H; Ibata T; Fukunaga K; Yoshioka Y; Kobayashi T; Sato S; Mizumoto K; Yoshimoto T; Lyu J; Dong T; Murao K
    Intern Med; 2019 Jul; 58(13):1913-1916. PubMed ID: 30918186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thyroid Autoimmunity and SARS-CoV-2 Infection.
    Fallahi P; Elia G; Ragusa F; Paparo SR; Patrizio A; Balestri E; Mazzi V; Benvenga S; Varricchi G; Gragnani L; Botrini C; Baldini E; Centanni M; Ferri C; Antonelli A; Ferrari SM
    J Clin Med; 2023 Oct; 12(19):. PubMed ID: 37835009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.